# ClinicalTrials.gov record NCT00775684

> PeptideScanner retained ClinicalTrials.gov record NCT00775684 at 2026-07-30T19:38:43.099Z. Its registry update date was 2022-06-07, and PeptideScanner's reviewed identity mapping was exenatide.

- Evidence object: `story:clinicaltrials-gov-nct00775684-exenatide:v1`
- Evidence domain: Clinical trials
- Date in source: 2022-06-07
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-09
- Story landing page: https://peptidescanner.com/stories/clinicaltrials-gov-nct00775684-exenatide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct00775684-exenatide-v1.json
- Content SHA-256: `fb9aba8e074b56e4c0437736a89a30988f57c6dfe2f9723f085eaca9c99e04f6`

## Claims and source pins

### Headline

ClinicalTrials.gov record NCT00775684 ([`ctg-observation-nct00775684-2022-06-07-2b2afcd80099`](#source-ctg-observation-nct00775684-2022-06-07-2b2afcd80099))

### Summary

PeptideScanner retained ClinicalTrials.gov record NCT00775684 at 2026-07-30T19:38:43.099Z. Its registry update date was 2022-06-07, and PeptideScanner's reviewed identity mapping was exenatide. ([`ctg-observation-nct00775684-2022-06-07-2b2afcd80099`](#source-ctg-observation-nct00775684-2022-06-07-2b2afcd80099))

### Paragraph 1

PeptideScanner retained ClinicalTrials.gov record NCT00775684 at 2026-07-30T19:38:43.099Z. Its registry update date was 2022-06-07, and PeptideScanner's reviewed identity mapping was exenatide. ([`ctg-observation-nct00775684-2022-06-07-2b2afcd80099`](#source-ctg-observation-nct00775684-2022-06-07-2b2afcd80099))

### Paragraph 2

This page reports a dated retained registry observation and does not assert the record's current status; registration is not evidence that an intervention is safe or effective. ([`ctg-observation-nct00775684-2022-06-07-2b2afcd80099`](#source-ctg-observation-nct00775684-2022-06-07-2b2afcd80099))

## Sources

<a id="source-ctg-observation-nct00775684-2022-06-07-2b2afcd80099"></a>
- **ClinicalTrials.gov record NCT00775684 · retained source version 2022-06-07:2b2afcd80099346da8cdb6e380ec9baeacfb1f2d25d7f19f76944a11fcf8bc7c** — ClinicalTrials.gov; class A. [Open source](https://clinicaltrials.gov/study/NCT00775684) (`ctg-observation-nct00775684-2022-06-07-2b2afcd80099`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reports the cited trial-registry entry and its status at observation. Registration or completion does not establish safety, effectiveness, or regulatory approval.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "ClinicalTrials.gov record NCT00775684." Version 1, published 2026-08-09. https://peptidescanner.com/evidence/v1/objects/clinicaltrials-gov-nct00775684-exenatide-v1.json SHA-256: fb9aba8e074b56e4c0437736a89a30988f57c6dfe2f9723f085eaca9c99e04f6.